Dongyuan Xing - Concepedia

Author

Dongyuan Xing

Jaeb Center for Health Research ORCID

Also Known As

Darrell M Wilson, Dongyuan Xing, William V Tamborlane

Publications

5.4K

Citations

H-Index

Concepts

All Affiliations

Jaeb Center for Health Research Stanford University Yale University Nemours Children's Clinic Eisai (United States)

About

Dongyuan Xing is an author at Jaeb Center for Health Research specializing in medicine, diabetes, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	949
2	Engineering	2	2	143
3	Public Health	2	2	32
4	Biomedical Engineering	2	2	143
5	Health Sciences	1	1	36

Dongyuan Xing

Publications

5.2K

Citations

H-Index

Page 1

	Year	Citations
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma Robert J. Motzer, B. Yа. Alekseev, Sun Young Rha, New England Journal of Medicine	2021	1.7K
Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial Roman Hovorka, Janet M. Allen, Daniela Elleri, The Lancet Family MedicineType 1Diabetes ManagementCrossover TrialInsulin Management	2010	449
High- and Low-Risk Profiles for the Development of Multiple Sclerosis Within 10 Years After Optic Neuritis Roy W. Beck, Jonathan D. Trobe, Pamela S. Moke, Archives of Ophthalmology	2003	400
Severe Hypoglycemia and Diabetic Ketoacidosis in Adults With Type 1 Diabetes: Results From the T1D Exchange Clinic Registry Ruth S. Weinstock, Dongyuan Xing, David M. Maahs, The Journal of Clinical Endocrinology & Metabolism	2013	332
Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry Eda Cengiz, Dongyuan Xing, Jenise C. Wong, Pediatric Diabetes	2013	243
Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial Roy W. Beck, Robin L. Gal, M. Tariq Bhatti, American Journal of Ophthalmology Ocular DiseaseOphthalmologyEye TrackingOptic NeuropathyOptic Neuritis	2003	236
A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to &lt;10 Years Nelly Mauras, Roy W. Beck, Dongyuan Xing, Diabetes Care	2011	203
Continuous Glucose Monitoring in Youth with Type 1 Diabetes: 12-Month Follow-Up of the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial H. Peter Chase, Roy W. Beck, Dongyuan Xing, Diabetes Technology & Therapeutics	2010	138
Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study Sara M. Tolaney, Kevin Kalinsky, Virginia Kaklamani, Clinical Cancer Research	2021	134
Optimal Sampling Intervals to Assess Long-Term Glycemic Control Using Continuous Glucose Monitoring Dongyuan Xing, Craig Kollman, Roy W. Beck, Diabetes Technology & Therapeutics	2011	121

Page 1